Compare BTMD & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTMD | GNSS |
|---|---|---|
| Founded | 2012 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.0M | 84.1M |
| IPO Year | 2021 | 1996 |
| Metric | BTMD | GNSS |
|---|---|---|
| Price | $2.21 | $1.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $2.83 | ★ $4.75 |
| AVG Volume (30 Days) | ★ 209.8K | 173.0K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 722.22 | 44.44 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $192,219,000.00 | $26,306,790.00 |
| Revenue This Year | $2.03 | $80.08 |
| Revenue Next Year | $6.58 | N/A |
| P/E Ratio | $39.00 | ★ N/A |
| Revenue Growth | N/A | ★ 29.50 |
| 52 Week Low | $1.27 | $1.40 |
| 52 Week High | $4.75 | $2.70 |
| Indicator | BTMD | GNSS |
|---|---|---|
| Relative Strength Index (RSI) | 54.83 | 42.61 |
| Support Level | $1.97 | $1.77 |
| Resistance Level | $2.79 | $1.88 |
| Average True Range (ATR) | 0.15 | 0.10 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 58.72 | 10.81 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.